India's biopharmaceutical excipients market is set for significant growth driven by the rise of biologics, government support like the PLI program, and growing outsourcing trends. Opportunities lie in ...

The nutraceutical excipients market is projected to rise from USD 4.98 billion in 2025 to USD 7.12 billion by 2030, expanding ...

DFE Pharma launches continuous manufacturing platform to accelerate and enable formulation development: Goch, Germany Wednesday, February 18, 2026, 12:00 Hrs [IST] DFE Pharma, a g ...

DFE Pharma has launched its Continuous Manufacturing (CM) platform, designed to support pharmaceutical companies in ...

Halozyme Therapeutics is entering a powerful earnings inflection. FY25 revenue grew 38% to $1.397 billion. Check out why I am bullish on HALO stock.

Tamil Nadu warns against unapproved oral nicotine pouches; advises public to avoid their purchase and use due to health risks.

FDA grants breakthrough status to Rybrevant Faspro for recurrent or metastatic HPV-negative head and neck cancer after prior therapy.

The American Hospital Association comments on request for information on the reauthorization of the Pandemic and All-Hazards Preparedness Act.

Suzanne Jansen, MSc, PharmD, ICON, says early-phase clinical success depends on flexible, simple formulations that support ...

Pharmaceutical products are essential for health, and they play and will continue to play a key role in disease prevention ...

When it comes to nutrition, vitamins can sometimes feel like a simple fix. But are they necessary? And what are the risks?

DFE Pharma introduces EcoLact 2030, delivering a data-verified CO2 reduction across its lactose portfolio: Goch, Germany Thursday, February 5, 2026, 15:00 Hrs [IST] DFE Pharma, a ...